
Related to this article


Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients

In a University of Toronto simulation, AI scribes cut documentation from 36.3% of each primary care visit to 11.2%, though total visit length didn’t change significantly.

A study published in Advanced Science used three AI models to screen thousands of approved drugs, identifying nine that inhibit Streptococcus pneumoniae, a bacterium increasingly resistant to antibiotics.

Federal contracts, Medicare pilots and new state laws have pushed artificial intelligence from the edges of clinical practice into the middle of it.
Advertisement
Advertisement
Trending on Medical Economics
1
On National Physician Suicide Awareness Day 2026, 71% of physicians say mental health stigma persists
2
Michigan man charged with billing Medicare for psychotherapy never provided; women less likely than men to receive intensive treatment; gambling disorder emergency visits nearly doubled in Ontario — Morning Medical Update
3
59% of health care workers plan to look for a new job in the next year, Harris Poll finds
4
Georgetown report calls for capping hospital prices, reforming prior authorization and curbing medical debt
5


